Concert Pharmaceutical

Shares of Concert Pharmaceuticals Inc (NASDAQ: CNCE) gained more than 13 percent Monday morning and traded above the $15 per share for the first time since early May after analysts at H.C. Wainwright & Co. initiated coverage of the stock with a bullish rating. Wainwright's Andrew Fein initiated...